SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Labcorp Holdings Inc. (LH) trades at a trailing P/E of 25.7, forward P/E of 15.1. Trailing earnings yield is 3.89%, forward earnings yield 6.64%. PEG 1.40. Graham Number is $158.19.
Criteria proven by this page:
- VALUE (36/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
- Forward P/E 15.1 (down from trailing 25.7) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 1.40 — between 1.0–2.0 indicates moderate valuation relative to growth.
- Trailing Earnings Yield 3.89% — roughly competitive with bond yields (~4.3%), moderate risk-reward. Forward yield improves to 6.64% as earnings recover.
- Analyst consensus target $321.33 (+19.5% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 58/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✗
VALUE
36/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — LH
Valuation Multiples
P/E (TTM)25.7
Forward P/E15.1
PEG Ratio1.40
Forward PEG0.21
P/B Ratio2.61
P/S Ratio1.62
EV/EBITDA14.6
Per Share Data
EPS (TTM)$10.62
Forward EPS (Est.)$17.85
Book Value / Share$104.69
Revenue / Share$169.11
FCF / Share$14.62
Yields & Fair Value
Earnings Yield3.89%
Forward Earnings Yield6.64%
Dividend Yield1.06%
Graham Number$158.19
SharesGrow IV$367.74 (+36.8%)
Analyst Target$321.33 (+19.5%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
15.4 |
0.25 |
2.05 |
1.17 |
- |
| 2017 |
11.1 |
0.15 |
2.06 |
1.34 |
- |
| 2018 |
12.5 |
-0.42 |
1.58 |
0.97 |
- |
| 2019 |
17.3 |
-5.01 |
1.88 |
1.23 |
- |
| 2020 |
10.9 |
0.12 |
1.80 |
1.22 |
- |
| 2021 |
11.0 |
0.20 |
2.54 |
1.99 |
- |
| 2022 |
14.4 |
-0.34 |
1.83 |
1.55 |
1.06% |
| 2023 |
47.4 |
-0.72 |
2.51 |
1.63 |
1.28% |
| 2024 |
25.8 |
0.30 |
2.39 |
1.48 |
1.26% |
| 2025 |
23.8 |
1.28 |
2.42 |
1.50 |
1.15% |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$7.02 |
$9.64B |
$732.1M |
7.6% |
| 2017 |
$12.21 |
$10.44B |
$1.27B |
12.1% |
| 2018 |
$8.61 |
$11.33B |
$883.7M |
7.8% |
| 2019 |
$8.36 |
$11.55B |
$823.8M |
7.1% |
| 2020 |
$15.88 |
$13.98B |
$1.56B |
11.1% |
| 2021 |
$24.38 |
$16.12B |
$2.38B |
14.7% |
| 2022 |
$13.96 |
$14.88B |
$1.28B |
8.6% |
| 2023 |
$4.77 |
$12.16B |
$418M |
3.4% |
| 2024 |
$8.84 |
$13.01B |
$746M |
5.7% |
| 2025 |
$10.46 |
$13.95B |
$876.5M |
6.3% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$17.86 |
$16.80 – $18.15 |
$14.67B |
$14.51B – $14.8B |
12 |
| 2027 |
$19.33 |
$17.99 – $19.96 |
$15.38B |
$15.13B – $15.65B |
12 |
| 2028 |
$21.07 |
$19.34 – $23.47 |
$16.18B |
$16.13B – $16.22B |
6 |
| 2029 |
$23.23 |
$22.83 – $23.58 |
$17.34B |
$17.11B – $17.54B |
4 |
| 2030 |
$23.80 |
$23.39 – $24.16 |
$15.22B |
$15.02B – $15.4B |
2 |
